La catena delle opzioni mostra i dati chiave delle opzioni azionarie di CME Gr a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per CME Gr..

CME Gr (NASDAQ:CME) Azioni, Catena delle Opzioni

CME Gr

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.

CME Group Inc

COMPUTER ENGNR&CONSLTNG by Computer Engineering & Consulting Ltd

Computer Engineering & Consulting Ltd

CHINA MEIDONG AUTO HLDGS by China Meidong Auto Hldgs

China MeiDong Auto Holdings Ltd

CM ENERGY TECH CO LTD by CM ENERGY TECH CO LTD

CM Energy Tech Co Ltd

CREO MED GROUP LTD by CREO MED GROUP LTD.

Creo Medical Group PLC

CoinMerge (BEP-20)

CMONEY INC by cMoney, Inc.

CI MARRT ALT END YLD HGD SRS UNT ETF

CME GROUP CL A ORD

News

Analyst Ratings

Trading Ideas

GBCI

IBIT

iShares Dow Jones US Financial Sector Index Fund

CNBC Halftime Report Final Trades: Glacier Bancorp, CME Group, iShares Bitcoin Trust, iShares US Financials ETF

AAPL

On CNBC, Kevin Simpson Announces Sold Apple Covered Calls, Trimmed Texas Pacific Land Postion, Buys More CME Group

Management

CME Group Extends CEO Terry Duffy's Contract Through 2026, Appoints Lynne Fitzpatrick As President And CFO, And Names Suzanne Sprague As New COO

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer said Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) is a buy. &#8220;This company is<a href="https://www.benzinga.com/quote/VRTX/analyst-ratings"> doing the lord's work,&#8221; he added.</a>
On Wednesday, Oppenheimer analyst Hartaj Singh maintained Vertex Pharmaceuticals with an Outperform and lowered the price target from $550 to $540.
CME Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) is a &#8220;strong buy,&#8221; Cramer said. &#8220;It is one of the most consistent, great companies.&#8221;
On Oct. 23, CME reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $2.65 per share. The company reported quarterly sales of $1.584 billion which beat the analyst consensus estimate of $1.579 billion.
The Mad Money host recommended buying T. Rowe Price Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>). &#8220;I think it's such a great company,&#8221; he added.
On Oct. 16, T. Rowe Price announced the appointment of Ben Riley to Head of Insurance.
&#8220;Enough with the selling&#8221; of Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), Cramer said.
Micron announced changes to its Board of Directors on Wednesday. Micron said Robert (Bob) Switz, its current Board Chair, will retire on Jan. 16, 2025, while the board approved the appointment of Micron&#8217;s President and CEO, Sanjay Mehrotra, to serve as Board Chair.
Price Action:
<ul>
<li>Vertex Pharmaceuticals shares gained 1% to settle at $475.08 on Wednesday.</li>
<li>CME Group shares rose 0.1% to close at $227.26 on Wednesday.</li>
<li>T. Rowe Price shares fell 0.5% to settle at $111.81 during the session.</li>
<li>Micron fell 3.8% to settle at $104.08 on Wednesday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41622545/wall-streets-most-accurate-analysts-spotlight-on-3-risk-off-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields</a></li>
</ul>
Image: Shutterstock

Markets

Media

TROW

VRTX

Jim Cramer: This Financial Stock Is 'One Of The Most Consistent, Great Companies'

CME Group Secures NFA Approval To Establish Futures Commission Merchant, Enhancing Risk Management And Expanding Client Services

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird raised AAON, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAON#NASDAQ">AAON</a>) price target from $114 to $130. Baird analyst Timothy Wojs upgraded the stock from Neutral to Outperform. AAON shares closed at $111.19 on Friday. See how other analysts view this stock.</li>
<li>BMO Capital increased the price target for Saia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIA#NASDAQ">SAIA</a>) from $465 to $495. BMO Capital analyst Fadi Chamoun maintained a Market Perform rating. Saia shares closed at $461.65 on Friday. <a href="https://www.benzinga.com/quote/SAIA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley raised the price target for Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>) from $71 to $72. Morgan Stanley analyst Meta Marshall upgraded the stock from Equal-Weight to Overweight. Nutanix shares closed at $61.59 on Friday. <a href="https://www.benzinga.com/quote/NTNX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Canaccord Genuity raised Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) price target from $278 to $298. Canaccord Genuity analyst George Gianarikas maintained a Buy rating. Tesla shares settled at $269.19 on Friday. <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham cut DENTSPLY SIRONA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRAY#NASDAQ">XRAY</a>) price target from $34 to $29. Needham analyst David Saxon maintained a Buy rating. DENTSPLY SIRONA shares closed at $23.31 on Friday. <a href="https://www.benzinga.com/quote/XRAY/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Benchmark raised Plexus Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLXS#NASDAQ">PLXS</a>) price target from $150 to $165. Benchmark analyst David Williams maintained a Buy rating. Plexus shares closed at $141.19 on Friday. <a href="https://www.benzinga.com/quote/PLXS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler cut the price target for Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) from $67 to $63. Piper Sandler analyst Peter Keith maintained an Overweight rating. Wayfair shares settled at $44.39 on Friday. <a href="https://www.benzinga.com/quote/W/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler raised CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) price target from $240 to $250. Piper Sandler analyst Patrick Moley maintained an Overweight rating. CME Group shares closed at $226.14 on Friday. <a href="https://www.benzinga.com/quote/CME/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital cut the price target for Hexcel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HXL#NYSE">HXL</a>) from $70 to $68. BMO Capital analyst John McNulty maintained a Market Perform rating. Hexcel shares closed at $62.53 on Friday. <a href="https://www.benzinga.com/quote/HXL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Keybanc boosted Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) price target from $86 to $87. Keybanc analyst Bradley Thomas maintained an Overweight rating. Walmart shares closed at $82.51 on Friday. <a href="https://www.benzinga.com/quote/WMT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying TSLA stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="519" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28091724/image-275-1024x519.png" alt="" class="wp-image-617086" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28091724/image-275-1024x519.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28091724/image-275-300x152.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28091724/image-275-768x389.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/28091724/image-275.png 1227w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41573022/how-to-earn-500-a-month-from-ford-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Ford Stock Ahead Of Q3 Earnings</a></li>
</ul>

Price Target

Pre-Market Outlook

AAON

NTNX

PLXS

SAIA

TSLA

XRAY

Tesla To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday

Piper Sandler analyst Patrick Moley maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Overweight and raises the price target from $240 to $250.

Piper Sandler Maintains Overweight on CME Gr, Raises Price Target to $250

RBC Capital analyst Ashish Sabadra reiterates CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Sector Perform and maintains $235 price target.

Reiteration

RBC Capital Reiterates Sector Perform on CME Gr, Maintains $235 Price Target

Oppenheimer analyst Owen Lau maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Outperform and raises the price target from $245 to $258.

Oppenheimer Maintains Outperform on CME Gr, Raises Price Target to $258

Citigroup analyst Christopher Allen maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Buy and raises the price target from $250 to $255.

Citigroup Maintains Buy on CME Gr, Raises Price Target to $255

Barclays analyst Benjamin Budish maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Equal-Weight and raises the price target from $219 to $231.

Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $231

Wall Street is on track for its third consecutive day of losses as investors grow cautious about risky assets, awaiting more clarity on U.S. fiscal and monetary policies and scrutinizing the latest <a href="https://www.benzinga.com/earnings">batch of corporate earnings.</a>
Both equities and commodities took a hit on Wednesday, while the U.S. dollar gained strength, attracting investor flows as traders moved to safer cash positions.
The U.S. dollar index, as tracked by the the&nbsp;Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), rose 0.5%, reaching levels last seen in late July. 
At midday in New York, the S&amp;P 500 was down 0.7%, attempting to hold support around the 5,800-point level. The Dow Jones also dropped 0.7%, and tech stocks, along with small caps, fared worse, sliding by 0.9%.
On the data front, mortgage applications declined for the fourth straight week, reflecting continued pressure <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41488744/mortgage-applications-fall-for-fourth-straight-week-as-high-rates-squeeze-homebuy">from elevated borrowing costs.</a>
Existing home sales fell by 1% in September to a seasonally adjusted annualized rate of 3.84 million, the lowest level since October 2010. This follows an upwardly revised 3.88 million in August and missed forecasts of 3.9 million.
Despite weak housing data, real estate stocks showed surprising resilience. The Vanguard Real Estate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNQ#NYSE">VNQ</a>) and the SPDR Homebuilders ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHB#NYSE">XHB</a>) moved higher after two straight sessions of losses.
Gold prices, as tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), fell more than 1%, pulling mining stocks down with it. Silver plummeted over 3%, retreating from 12-year highs reached on Tuesday.
Oil prices slipped by 1%, while Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) tumbled 2%. 
<h1 class="wp-block-heading">Wednesday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,815.02</td>
<td>-0.7%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,625.59</td>
<td>-0.7%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,213.10</td>
<td>-0.9%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,196.24</td>
<td>-0.9%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated 12:00 p.m. ET </figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent102224&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.6% to $579.72.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.7% lower to $426.41.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 1% to $491.16.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.7% $219.80.</li>
<li>The Real Estate Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>) outperformed, up 0.6%. The Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) lagged, down 1%.</li>
</ul>
<h1 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h1>
<ul>
<li>Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) fell 2.4% after reporting a worse-than-expected losses<a href="https://www.benzinga.com/news/earnings/24/10/41486950/boeing-q3-earnings-revenue-and-profit-decline-cultural-challenges-ceo-ortberg-vows-transformation"> last quarter</a>.</li>
</ul>
Other stocks reacting to earnings included:
<ul>
<li>Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), up 3.5%.</li>
<li>Baker Hughes Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>), up 3.9%.</li>
<li>Seagate Technology Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>), down over 7%.</li>
<li>Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>), up over 6%.</li>
<li>Manhattan Associates Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>), down over 7%.</li>
<li>East West Bancorp. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>), up over 7%.</li>
<li>Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>), down over 13%.</li>
<li>Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), down 2.2%. </li>
<li>Thermo Fisher Scientific Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>), down 2.9%.</li>
<li>NextEra Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>), down 0.1%. </li>
<li>AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>), up 3.8%. </li>
<li>Boston Scientific Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>), down 3.7%. </li>
<li>CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), down 0.9%. </li>
<li>GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), down 1.6%. </li>
<li>Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>), down 2.6%. </li>
<li>Vertiv Holdings LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>), down 2.8%. </li>
<li>Old Dominion Freight Line Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>), down 4.8%. </li>
</ul>
Large-cap companies reporting earnings after the close include Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), T-Mobile US Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>), International Business Machines Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>), ServiceNow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>), Lam Research Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), Newmont Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>), United Rentals Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>), Las Vegas Sands Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>), Raymond James Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>). 
Read Now:
<ul>
<li><a href="https://www.benzinga.com/markets/bonds/24/10/41455678/gold-on-track-for-best-year-since-1979-veteran-investor-says-sell-bonds-buy-gold">Gold On Track For Best Year Since 1979: Veteran Investor Says &#8216;Sell Bonds, Buy Gold&#8217;</a></li>
</ul>

Equities

Large Cap

Macro Economic Events

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

Econ #s

Economics

Tech

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

ENPH

EWBC

LRCX

MANH

ODFL

TMUS

PowerShares DB US Dollar Index Bullish Fund

XLRE

Select Sector SPDR-Consumer Discretionary

Wall Street Slumps For Third Straight Day As Investor Sentiment Fades, Dollar Strength Resumes, Boeing Disappoints: What's Driving Markets Wednesday?

Earnings

CME Group Quarterly ADV 28.3M Contracts

CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) reported quarterly earnings of $2.68 per share which beat the analyst consensus estimate of $2.65 by 1.13 percent. The company reported quarterly sales of $1.584 billion which beat the analyst consensus estimate of $1.579 billion by 0.33 percent. This is a 18.42 percent increase over sales of $1.338 billion the same period last year.

Earnings Beats

CME Gr Q3 2024 Adj. EPS $2.68 Beats $2.65 Estimate, Sales $1.584B Beat $1.579B Estimate

CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) is set to give its latest quarterly earnings report on Wednesday, 2024-10-23. Here's what investors need to know before the announcement.
Analysts estimate that CME Gr will report an earnings per share (EPS) of $2.57. 
The market awaits CME Gr's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
The company's EPS beat by $0.03 in the last quarter, leading to a 1.08% increase in the share price on the following day.
Here's a look at CME Gr's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>2.53</td>
<td>2.45</td>
<td>2.28</td>
<td>2.22</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>2.56</td>
<td>2.50</td>
<td>2.37</td>
<td>2.25</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.0%</td>
<td>-0.0%</td>
<td>-2.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729616464_0.png" alt="eps graph" />
<h3>Performance of CME Gr Shares</h3>
Shares of CME Gr were trading at $227.05 as of October 21. Over the last 52-week period, shares are up 5.79%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/CME/earnings">To track all earnings releases for CME Gr visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What to Expect from CME Gr's Earnings

Morgan Stanley analyst Mike Cyprys maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Equal-Weight and raises the price target from $210 to $233.

Morgan Stanley Maintains Equal-Weight on CME Gr, Raises Price Target to $233

Oppenheimer analyst Owen Lau maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Outperform and raises the price target from $228 to $245.

Oppenheimer Maintains Outperform on CME Gr, Raises Price Target to $245

<ul>
<li>Record&nbsp;Europe,&nbsp;Middle East&nbsp;and&nbsp;Africa&nbsp;(EMEA) ADV&nbsp;of&nbsp;6.2M, up&nbsp;30%&nbsp;in&nbsp;Q3&nbsp;2024</li>
<li>Asia Pacific&nbsp;(APAC) ADV of&nbsp;1.8M, up&nbsp;28%</li>
</ul>

CME Group International ADV Reaches 8.4M Contracts In Q3 2024, Bolstered By 30% Growth In EMEA And 28% In APAC

Redburn Atlantic analyst Simon Clinch downgrades CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) from Buy to Neutral and announces $244 price target.

Downgrades

Redburn Atlantic Downgrades CME Gr to Neutral, Announces $244 Price Target

Piper Sandler analyst Patrick Moley maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Overweight and raises the price target from $225 to $240.

Piper Sandler Maintains Overweight on CME Gr, Raises Price Target to $240

In a report released yesterday, Michael Cyprys from Morgan Stanley maintained a Hold rating on CME Group (CME – Research Report), with a price targ...

CME Group: Hold Rating Maintained Amid Modest EPS Adjustments and Cautious Price Target Increase

Trump Or Harris? Here Are 3 Undervalued Dividend Stocks That Should Win No Matter What

Trade On, Cash In: Why CME Group Is My Pick For Income And Growth

Parnassus Core Equity Fund Q3 2024 Commentary

CME Group reports October ADV of 24.3M contracts

CBOE downgraded to Underweight at Morgan Stanley amid growth risk, rich valuation

SA Asks: How will the U.S. election results impact crypto?

CME Group ( ($CME) ) just unveiled an update. CME Group has extended CEO Terry Duffy's contract until the end of 2026 to ensure continued strategic...

CME Group Announces Leadership Changes for Future Growth

Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q3 2024 Update

The Trump Dip - Here's What I'm Buying To Improve My Dividend Portfolio

ADBE

AMAT

AMZN

AVGO

BALL

CBOE

CBRE

CHTR

COIN

FBTC

FERG

FLUT

GBTC

GOOG

GOOGL

IBKR

INTC

MARA

MSFT

MSTR

NDAQ

NVDA

ORCL

PDYPY

PYPL

RIOT

SNPS

SPGI

TCMEF

TCOM

TNET

TRPCF

TSMWF

UBER

Screenshot 2024-05-07 at 5.26.30 PM

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

With The Cryptocurrency Market Historically Tumultuous, Regulated Futures Brokers Like EdgeClear May Offer More Security Than Their Spot Counterparts

Press Releases

CME Group Announces First Trades of CBL Australian Carbon Credit Unit (ACCU) Futures

CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q3 2024

CME Group Announces First Trades of Spodumene Futures

CME Group Receives Approval to Establish Futures Commission Merchant

Commodities

Henry Hub Futures Reach Record Open Interest as International Demand Soars

CME Group Reports October 2024 ADV of 24.3 Million Contracts

Farmer sentiment in October rebounded ahead of the U.S. election

Dividends

CME Group Declares Quarterly Dividend

CME Group Announces Winners of the 21st Annual University Trading Challenge

CME Group Announces Employment Agreement Extension for Chairman and Chief Executive Officer Terry Duffy

Comments

CME Gr

CME Gr (CME) Opzioni

CME Gr (NASDAQ:CME) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO